194 related articles for article (PubMed ID: 19757197)
21. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.
Guillou L; Wadden C; Coindre JM; Krausz T; Fletcher CD
Am J Surg Pathol; 1997 Feb; 21(2):130-46. PubMed ID: 9042279
[TBL] [Abstract][Full Text] [Related]
22. Proximal-type epithelioid sarcoma in the pelvic soft tissues.
Fukunaga M; Ushigome S
APMIS; 1999 Mar; 107(3):283-8. PubMed ID: 10223300
[TBL] [Abstract][Full Text] [Related]
23. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
Rekhi B; Thomas A
Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
[TBL] [Abstract][Full Text] [Related]
24. SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.
Brenca M; Rossi S; Lorenzetto E; Piccinin E; Piccinin S; Rossi FM; Giuliano A; Dei Tos AP; Maestro R; Modena P
Mol Cancer Ther; 2013 Jun; 12(6):1060-72. PubMed ID: 23576573
[TBL] [Abstract][Full Text] [Related]
25. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Orrock JM; Abbott JJ; Gibson LE; Folpe AL
Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
[TBL] [Abstract][Full Text] [Related]
27. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
[TBL] [Abstract][Full Text] [Related]
28. [Epithelioid sarcoma: morphologic variants and differential diagnosis].
Mentzel T
Pathologe; 2010 Mar; 31(2):135-41. PubMed ID: 19997734
[TBL] [Abstract][Full Text] [Related]
29. INI Expressing Epithelioid Sarcoma with Osteoclastic Giant Cells in a Child: A Case Report with Summary of Prior Published Cases.
Bhattacharyya R; Ghosh R; Saha K; Chatterjee U
Fetal Pediatr Pathol; 2017 Aug; 36(4):325-331. PubMed ID: 28541826
[TBL] [Abstract][Full Text] [Related]
30. Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of
Srinivasan A; Liu M; Parham D; Li M; Wang X; Lu X; Li S; Zhang L; Yu Z
Fetal Pediatr Pathol; 2020 Feb; 39(1):51-61. PubMed ID: 31215292
[No Abstract] [Full Text] [Related]
31. Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma.
Mularz K; Harazin-Lechowska A; Ambicka A; Kruczak A; Rozmus-Piętoń M; Marchińska-Osika U; Swiątkiewicz I; Król M; Pabis D; Januś G; Ryś J
Pol J Pathol; 2012 Nov; 63(3):179-83. PubMed ID: 23161234
[TBL] [Abstract][Full Text] [Related]
32. Epithelioid sarcoma.
Armah HB; Parwani AV
Arch Pathol Lab Med; 2009 May; 133(5):814-9. PubMed ID: 19415960
[TBL] [Abstract][Full Text] [Related]
33. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
34. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
[TBL] [Abstract][Full Text] [Related]
35. Epithelioid sarcoma or malignant rhabdoid tumor of soft tissue? Epithelioid immunophenotype and rhabdoid karyotype.
Molenaar WM; DeJong B; Dam-Meiring A; Postma A; DeVries J; Hoekstra HJ
Hum Pathol; 1989 Apr; 20(4):347-51. PubMed ID: 2649435
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Iwasaki H; Sonobe H; Goto H; Kusakabe H; Takahira T; Kobayashi C; Kawaguchi K; Saito T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 Jun; 19(6):820-31. PubMed ID: 16557275
[TBL] [Abstract][Full Text] [Related]
37. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies.
Alikhan MB; Pease G; Watkin W; Grogan R; Krausz T; Antic T
Hum Pathol; 2017 Mar; 61():158-163. PubMed ID: 27769872
[TBL] [Abstract][Full Text] [Related]
38. Prognostic determinants in epithelioid sarcoma.
Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
[TBL] [Abstract][Full Text] [Related]
39. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
40. Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare.
Cascio MJ; O'Donnell RJ; Horvai AE
Mod Pathol; 2010 Apr; 23(4):574-80. PubMed ID: 20118913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
